Plasma and cerebrospinal fluid levels of baclofen (lioresal®) at optimal therapeutic responses in spastic paresis☆
References (13)
- et al.
Zur Objektivierbarkeit des myotonolytischen Effektes eines Aminobuttersäurederivates (CIBA 34647-Ba)
Wien. med. Wschr.
(1967) - et al.
The chemistry and kinetics of Lioresal
Postgrad. med. J.
(1972) - et al.
The metabolism and pharmacokinetics of Lioresal
- et al.
Sites of action of a new muscle relaxant (baclofen, Lioresal®, Ciba 34 647-Ba)
J. int. med. Res.
(1974) - et al.
Baclofen in the treatment of spasticity
Brit. med. J.
(1971) Doppelblindstudie über den antispastischen Effekt von β-(4-Chlorophenyl)-γ-Aminobuttersäure (CIBA) bei multipler Sklerose
Nervenarzt
(1968)
There are more references available in the full text version of this article.
Cited by (0)
- ☆
This study was supported by grants from the Swedish Medical Research Council and the Swedish Multiple Sclerosis Foundation.
Copyright © 1974 Published by Elsevier B.V.